FEDERATED HERMES, INC. - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 128 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,825
-25.0%
1,4150.0%0.00%
Q2 2023$2,434
+13.9%
1,4150.0%0.00%
Q1 2023$2,137
-62.3%
1,415
-60.1%
0.00%
Q4 2022$5,667
-5.6%
3,542
-16.8%
0.00%
Q3 2022$6,000
-14.3%
4,257
+11.1%
0.00%
Q2 2022$7,000
+600.0%
3,833
+4632.1%
0.00%
Q1 2022$1,000
-100.0%
81
-100.0%
0.00%
-100.0%
Q4 2021$4,163,000
-15.0%
961,474
-0.0%
0.01%
-11.1%
Q3 2021$4,895,000
-17.0%
961,597
+3.2%
0.01%
-18.2%
Q2 2021$5,900,000
+28.6%
932,007
+57.1%
0.01%
+22.2%
Q1 2021$4,587,000
+93.1%
593,421
+63.6%
0.01%
+80.0%
Q4 2020$2,375,000
+1830.9%
362,658
+1863.3%
0.01%
Q3 2020$123,000
+115.8%
18,472
+170.9%
0.00%
Q2 2020$57,000
+11.8%
6,819
-2.2%
0.00%
Q3 2019$51,000
-98.6%
6,970
-94.5%
0.00%
-100.0%
Q1 2018$3,583,000
+144.7%
125,932
+81.6%
0.01%
+150.0%
Q4 2017$1,464,00069,3500.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,500,000$7,635,0001.78%
Altium Capital Management LP 1,233,642$6,279,0001.65%
RA Capital Management 3,500,000$17,815,0000.25%
Soleus Capital Management, L.P. 261,050$1,329,0000.21%
Affinity Asset Advisors, LLC 125,000$636,0000.16%
PLATINUM INVESTMENT MANAGEMENT LTD 1,078,103$5,488,0000.16%
Point72 Asset Management, L.P. 6,303,025$32,082,0000.14%
GSA CAPITAL PARTNERS LLP 249,146$1,268,0000.13%
Candriam S.C.A. 3,305,940$16,826,0000.11%
RTW INVESTMENTS, LP 1,400,939$7,131,0000.11%
View complete list of CYTOMX THERAPEUTICS INC shareholders